Insulin sensitivity of glucose disposal and lipolysis:: no influence of common genetic variants in IRS-1 and CAPN10

被引:15
作者
Stumvoll, M [1 ]
Wahl, HG [1 ]
Machicao, F [1 ]
Häring, H [1 ]
机构
[1] Univ Tubingen, Dept Endocrinol & Metab, Tubingen, Germany
关键词
insulin resistance; lipolysis; glycerol; stable isotopes; euglycaemic hyperinsulinaemic clamp;
D O I
10.1007/s00125-002-0793-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. This study aimed to assess the physiologic relationships between insulin sensitivity of lipolysis and that of glucose disposal and whether two common genetic polymorphisms associated with insulin resistance partially explained the remaining variation. Methods. We measured suppression of lipolysis (isotopically [primed-continuous infusion of d5 glycerol] measured glycerol rate of appearance) and glucose disposal during a three-step (n = 24) or standard (n 57) hyperinsulinaemic euglycaemic clamp in 81 healthy subjects. We also compared insulin sensitivity of lipolysis in carriers (vs. wildtype controls) of the CAPN10 UCSNP43 G/A and IRS-1 Gly972Arg polymorphisms. Results. We observed a significant correlation between insulin sensitivity of glucose disposal and insulin sensitivity of lipolysis (r = -0.39, p < 0.001) which was retained, albeit weaker, after adjusting for BMI (r = -0.27, p = 0.002). No significant difference in insulin sensitivity of lipolysis was found between Gly/Gly compared with X/Arg (IRS-1) and GIG compared with G/A + A/A (CAPN10) (all p values > 0.15). Conclusion/interpretation. Insulin sensitivity of lipolysis has a considerable variation in healthy human beings and independently explains about 10% of the variation in insulin sensitivity of glucose disposal (or vice versa). It is possible that mediated through NEFAs, insulin resistance of glucose disposal is secondary to that of lipolysis. Alternatively, the biological variation in insulin sensitivity, to some extent, affects both systems in parallel. Neither of the two putatively insulin resistance-related polymorphisms that were tested contributed measurably to the biological variation of insulin sensitivity of lipolysis.
引用
收藏
页码:651 / 656
页数:6
相关论文
共 33 条
[1]   A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling - Evidence from transfection studies [J].
Almind, K ;
Inoue, G ;
Pedersen, O ;
Kahn, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2569-2575
[2]   AMINO-ACID POLYMORPHISMS OF INSULIN-RECEPTOR SUBSTRATE-1 IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
ALMIND, K ;
BJORBAEK, C ;
VESTERGAARD, H ;
HANSEN, T ;
ECHWALD, S ;
PEDERSEN, O .
LANCET, 1993, 342 (8875) :828-832
[3]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[4]   A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance [J].
Baier, LJ ;
Permana, PA ;
Yang, XL ;
Pratley, RE ;
Hanson, RL ;
Shen, GQ ;
Mott, D ;
Knowler, WC ;
Cox, NJ ;
Horikawa, Y ;
Oda, N ;
Bell, GI ;
Bogardus, C .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (07) :R69-R73
[5]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[6]   FAT-METABOLISM IN HUMAN OBESITY [J].
CAMPBELL, PJ ;
CARLSON, MG ;
NURJHAN, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :E600-E605
[7]  
CAMPBELL PJ, 1992, AM J PHYSIOL, V263, pE1063
[8]   INSULIN-RESISTANCE - INTERACTIONS BETWEEN OBESITY AND A COMMON VARIANT OF INSULIN-RECEPTOR SUBSTRATE-1 [J].
CLAUSEN, JO ;
HANSEN, T ;
BJORBAEK, C ;
ECHWALD, SM ;
URHAMMER, SA ;
RASMUSSEN, S ;
ANDERSEN, CB ;
HANSEN, L ;
ALMIND, K ;
WINTHER, K ;
HARALDSDOTTIR, J ;
BORCHJOHNSEN, K ;
PEDERSEN, O .
LANCET, 1995, 346 (8972) :397-402
[9]  
DEBODO RC, 1963, RECENT PROG HORM RES, V19, P445
[10]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368